openPR Logo

Press Releases from Chameleon Pharma Consulting (10 total)

Product Registration for OTC, Phyto, substance-based MD, FS & Cosmetics in Mexic …

Mexico is the second-largest OTC & pharma market in Latin America, with premium pricing and well-regulated environment by COFEPRIS (MoH). The Mexican market is very attractive to enter for foreign players. Many product segments have premium prices above the EU level. We, Chameleon Pharma Consulting Group, have more than 20 years of commercial, market entry & regulatory experience in Mexico. That is why our experts have prepared a regulatory webinar to

Chameleon Pharma Consulting to present Market Entry Strategies at OTCToolbox Con …

Chameleon Pharma Consulting is a healthcare consulting firm with a focus on the emerging markets in Asia, Latin America, CIS / CEE, US / Canada and the Middle East. We support pharma/OTC companies to enter new markets, develop market entry strategies, select product portfolios for focus markets, overcome regulatory hurdles and much more. With more than 20 years of experience in the pharmaceutical industry and a large network of experts,

Addressing Covid-19 for your business means to be part of the solution!

Many of our clients are wondering how to best tackle business in LATAM, Asia, Europe, US/Canada and CIS/CEE in light of the current Covid-19 crisis, and what topics to address first. Seven tips to consider for International OTC, Pharma, and Medical Device Leaders. In the following, we have put together some thoughts for OTC, Pharma, and Medical Device Leaders for overcoming the Covid-19 crisis. The article might support you to reflect on

Chameleon Pharma Consulting entwickelt neues „International Market Analysis” …

Internationale Wachstumsstrategien in der Gesundheitsbranche, wie beispielsweise in Consumer Health, Pharma Rx & OTC, Medical Devices, Kosmetik, stehen immer mehr in Abhängigkeit der aufstrebenden Länder. Eine hohe Wachstumsrate lässt sich insbesondere in Lateinamerika, Asien, den GUS- und CEE-Staaten, sowie im Mittleren Osten und in ausgewählten europäischen Segmenten verzeichnen. Mit Blick auf die Zukunft können wir sagen, dass die Emerging Markets in den nächsten 10-20 Jahren die größten Wachstumspotentiale innehaben. Um

CPHI Frankfurt 2017 - Sind Sie schon in den richtigen Emerging Markets?

Die CPhI Worldwide findet in diesem Jahr in Frankfurt am Main, dem Finanzzentrum Europas und der fünftgrößten Stadt Deutschlands statt. Die weltweit größte Pharma-Veranstaltung ereignet sich zwischen dem 24. und 26. Oktober 2017. Es werden über 2.500 Aussteller aus 153 Ländern zusammenkommen. Wussten Sie, dass bis 2030 40% des weltweiten OTC & Rx. Umsatzes in den Emerging Markets, Lateinamerika, Mittlerer Osten, GUS, Osteuropa und Asien erzielt werden? Haben Sie bereits analysiert

Emerging Markets Forum: OTC Pharma go-to-market strategies, partnerships and mar …

13 – 14 March 2017 Kempinski Hotel Bristol, Berlin, Germany On March 13th & 14th 2017, OTC & Pharma global industry leaders will gather at the Kempinski Hotel in Berlin, to attend the Emerging Markets Forum. This unique two-day event, which is the biggest of its kind, will have a focus on the economic outlook for emerging markets, global product portfolio strategies and global go-to-market strategies for pharma and over-the-counter (OTC) products.

Pharmacy chains in Russia – an interesting outlook

“Obviously, the drug store chains in Russia are becoming more and more important. However, only a few good retail concepts are available at present, which gives a great potential in this area”, says Reiner Christensen from Chameleon Pharma Consulting. “In our views, there is a clear trend that further consolidation among pharmacies will take place and the market share of retail chains will be increasing year by year.” The 1st pharmacy

Chameleon Pharma Consulting: Healthcare reform in Ukraine - selling of medicine …

On December 29, 2011 the Ministry of Health (an organ that provides the introduction of state policy in public health) has put a new law concerning internet sales of medicines and drugs in place. From this date the changes for distribution drugs to patients and consumers are the following: • Distance sale of medicine (by post, via Internet or other retail shops with no pharmacy status) are prohibited • Sale of medicine is

Chameleon Pharma Consulting Report: Russian Pharma Companies and Market Grow

If Managers could vote for a Healthcare growth paradise on earth, it would certainly be for the CIS or CEE Markets! The crisis has gone and the CIS or CEE healthcare markets develop well. No other place on earth does show sales growth numbers of more than 15%. If we compare countries like Russia and Ukraine with France and the UK in terms of number of inhabitants , those markets in

At Chameleon Pharma Consulting the Pharma know-how has doubled

Berlin, 01 September 2011 – Chameleon Pharma Consulting has a new management associate: Andreas Masel is Pharma expert for more than 35 years. His special segments are Pharma Rx. and OTC in Eastern Europe and the CIS countries. Together with Mr. Masel Chameleon Pharma has more than 50 years of Pharma Experience especially regarding Russia, Kazakhstan, Ukraine, Poland, Romania etc. As an expert for export and international business relations Mr. Masel

Go To Page:   1 2 3 4 5 6 7 8 9 10